Osimertinib for leptomeningeal metastases in NSCLC
Volume: 21, Issue: 1, Pages: e17 - e17
Published: Jan 1, 2020
Abstract
Osimertinib showed antitumour activity in the CNS of patients with EGFR-mutated advanced non-small-cell lung cancer (NSCLC) and leptomeningeal metastases, according to a recent...
Paper Details
Title
Osimertinib for leptomeningeal metastases in NSCLC
Published Date
Jan 1, 2020
Volume
21
Issue
1
Pages
e17 - e17
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History